Position in ORKA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$136,088,721
+$89,252,496 QoQ
Shares Held
1,429,954
+49.8% QoQ
Ownership
2.16%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#16
of 254 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ORKA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,426,307 across 521 Biotechnology names. ORKA ranks #39 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in ORKA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $136,088,721 | 1,429,954 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $46,836,225 | 954,867 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $28,567,386 | 942,507 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $13,268,161 | 689,972 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $7,930,021 | 707,406 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $3,617,521 | 352,585 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $6,639,484 | 342,418 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $342,746 | 13,984 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 ABIO | — | 161,735 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 ABIO | — | 142,349 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 ABIO | — | 142,349 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 ABIO | — | 142,349 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 ABIO | — | 155,635 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 ABIO | — | 155,635 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 ABIO | — | 155,635 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 ABIO | — | 155,870 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 ABIO | — | 102,911 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 ABIO | — | 96,326 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 ABIO | — | 95,358 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 ABIO | — | 95,358 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 ABIO | — | 87,659 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 ABIO | — | 79,151 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 ABIO | — | 32,752 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||